DOI QR코드

DOI QR Code

Esophageal tolerance to high-dose stereotactic radiosurgery

  • Lee, Bo Mi (Department of Radiation Oncology, CHA Bundang Medical Center, CHA University) ;
  • Chang, Sei Kyung (Department of Radiation Oncology, CHA Bundang Medical Center, CHA University) ;
  • Ko, Seung Young (Department of Radiation Oncology, CHA Bundang Medical Center, CHA University) ;
  • Yoo, Seung Hoon (Department of Radiation Oncology, CHA Bundang Medical Center, CHA University) ;
  • Shin, Hyun Soo (Department of Radiation Oncology, CHA Bundang Medical Center, CHA University)
  • Received : 2013.09.23
  • Accepted : 2013.10.14
  • Published : 2013.12.31

Abstract

Purpose: Esophageal tolerance is needed to guide the safe administration of stereotactic radiosurgery (SRS). We evaluated comprehensive dose-volume parameters of acute esophageal toxicity in patients with spinal metastasis treated with SRS. Materials and Methods: From May 2008 to May 2011, 30 cases in 27 patients with spinal metastasis received single fraction SRS to targets neighboring esophagus. Endpoints evaluated include length (mm), volume (mL), maximal dose (Gy), and series of dose-volume thresholds from the dose-volume histogram (volume of the organ treated beyond a threshold dose). Results: The median time from the start of irradiation to development of esophageal toxicity was 2 weeks (range, 1 to 12 weeks). Six events of grade 1 esophageal toxicity occurred. No grade 2 or higher events were observed. $V_{15}$ of external surface of esophagus was found to predict acute esophageal toxicity revealed by multivariate analysis (odds radio = 1.272, p = 0.047). Conclusion: In patients with spinal metastasis who received SRS for palliation of symptoms, the threshold dose-volume parameter associated with acute esophageal toxicity was found to be $V_{15}$ of external surface of esophagus. Restrict $V_{15}$ to external surface of esophagus as low as possible might be safe and feasible in radiosurgery.

Keywords

References

  1. Squier CA, Kremer MJ. Biology of oral mucosa and esophagus. J Natl Cancer Inst Monogr 2001;(29):7-15.
  2. Rahmathulla G, Djemil T, Chao S, Emch T, Angelov L. Impact of cervico-thoracic region spine radiosurgery on adjacent organs at risk. Int J Radiat Oncol Biol Phys 2010;78(3 Suppl):S290-1 .
  3. Werner-Wasik M, Yorke E, Deasy J, Nam J, Marks LB. Radiation dose-volume effects in the esophagus. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S86-93. https://doi.org/10.1016/j.ijrobp.2009.05.070
  4. Dieleman EM, Senan S, Vincent A, et al. Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration. Int J Radiat Oncol Biol Phys 2007;67:775-80. https://doi.org/10.1016/j.ijrobp.2006.09.054
  5. Cohen RJ, Paskalev K, Litwin S, Price RA Jr, Feigenberg SJ, Konski AA. Esophageal motion during radiotherapy: quantification and margin implications. Dis Esophagus 2010;23:473-9. https://doi.org/10.1111/j.1442-2050.2009.01037.x
  6. Poltinnikov IM, Fallon K, Xiao Y, Reiff JE, Curran WJ Jr, WernerWasik M. Combination of longitudinal and circumferential three-dimensional esophageal dose distribution predicts acute esophagitis in hypofractionated reirradiation of patients with non-small-cell lung cancer treated in stereotactic body frame. Int J Radiat Oncol Biol Phys 2005;62:652-8. https://doi.org/10.1016/j.ijrobp.2004.10.030
  7. Hirota S, Tsujino K, Endo M, et al. Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy. Int J Radiat Oncol Biol Phys 2001;51:291-5.
  8. Singh AK, Lockett MA, Bradley JD. Predictors of radiationinduced esophageal toxicity in patients with non-smallcell lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2003;55:337-41. https://doi.org/10.1016/S0360-3016(02)03937-8
  9. Montebello JF, Aron BS, Manatunga AK, Horvath JL, Peyton FW. The reirradiation of recurrent bronchogenic carcinoma with external beam irradiation. Am J Clin Oncol 1993;16:482-8. https://doi.org/10.1097/00000421-199312000-00004
  10. Kahn D, Zhou S, Ahn SJ, et al. "Anatomical ly-correct" dosimetric parameters may be better predictors for esophageal toxicity than are trad itional CT-based metrics. Int J Radiat Oncol Biol Phys 2005;62:645-51. https://doi.org/10.1016/j.ijrobp.2004.10.042
  11. Gomez DR, Hunt MA, Jackson A, et al. Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy. Radiother Oncol 2009;93:414-8. https://doi.org/10.1016/j.radonc.2009.10.017
  12. Timmerman RD. An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat OncoI2008;18:215-22. https://doi.org/10.1016/j.semradonc.2008.04.001